Page 22 - Pharma

Dow India launches ultrafiltration technology for water treatment

With the new technology, IntegraFlux ultrafiltration modules, the company is targeting industries such as energy, textiles, pharmaceutical, etc for providing effluent management solutions

Global PE firm TPG Growth invests $ 33 mn in Rhea Healthcare

Including Motherhood, the brand name of Rhea Healthcare's mother and child care centres, TPG Growth's investments in healthcare companies across India and Sri Lanka now total nearly $ 250 mn

Essel Propack opens packaging facility in Colombia

The new facility, with capacity to manufacture 180 million laminated plastic tubes in a year, will serve the high-value beauty & cosmetics category along with pharma sector

Ajanta Pharma receives US FDA approval for omeprazole capsules

The company has launched omeprazole and sodium bicarbonate capsule, a generic version of Santarus Inc's Zegerid, in two strengths - 20 mg/1100 mg and 40 mg/1100 mg

Dr Reddy's launches stomach ulcer treatment drug in US

The drug - omeprazole and sodium bicarbonate capsules - reportedly had US sales of approximately $ 306 million for the last twelve months ending in May 2016

SPARC licenses epilepsy drug Elepsia XR to Sun Pharma

The company will receive an up-front payment of $10 million from Sun Pharma, which will market the product (levetiracetam extended release tablets) in the US

Six government initiatives that have major impact on Indian logistics sector

Diesel de-regulation, big thrust on building highways, Carriers' Act, dedicated freight corridor, GST and Make in India campaign can be game changers for logistics sector, says Anil Syal

Biocon introduces insulin glargine in Japan for diabetes patient

The company, through its partner Fujifilm Pharma, aims to capture a significant share of the Japanese glargine market, estimated by IMS Health at $ 144 million

Amgen and Daiichi Sankyo to jointly commercialise biosimilars in Japan

The deal includes several products in late-stage development, including biosimilars of adalimumab, bevacizumab and trastuzumab

Vascon Engineers opens clean room partitioning systems plant in Thane

While clean room partitioning systems are mainly used in pharma and healthcare industry, demand is also expected to come from defence, auto component, semi-conductor and solar sectors

Granules India buys 12.5% stake in USpharma

With this, Hyderabad based pharma company will have right of first refusal to market the select products which are under development by USpharma

Indian companies gearing up to solve the biosimilars puzzle

US President is pushing for setting the exclusivity period for biologic drugs at 7 years instead of 12. If this happens, Indian companies should be ready for a windfall of opportunities

Plastic technology provider Rochling to invest Euro 35 mn in German plant

Investment will give a considerable boost to the company's position in the manufacture of primary packaging for the pharmaceutical and diagnostic industry

AMRI completes acquisition of Italian API maker Euticals

The acquisition positions AMRI as one of the largest independent developers and suppliers of active pharmaceutical ingredients (APIs) to the pharmaceutical industry in Europe

Suven Life bags patents for CNS drug in India and South Africa

The company has received patents for its new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases

Apax Partners acquires subsidiaries of Spanish pharma firm Invent Farma

This follows Apax Partners' recent acquisition of Neuraxpharm Arzneimittel GmbH, a leading German pharmaceutical company

Nanotechnology breathes life into cosmeceuticals

Nanoparticles are transforming the cosmetics industry, with many companies focusing on developing nanoparticles for applications in cosmeceuticals, says Dr Mosongo Mouka

Why 'quality' should matter for Make in India campaign

As India gallops with rest of the economies, a rigorous system of standards, replete with robust mechanisms for implementation and enforcement, is crucial for sustained growth, says Suresh Sugavanam

Sun Pharma rolls out anti-cancer Gemcitabine InfuSMART in Europe

It will launch Gemcitabine InfuSMART - a technology in which oncology products are developed in a ready-to-administer bag - in Netherlands, UK, Spain, Germany, Italy and France

Cipla aims to make biosimilars affordable with new South African plant

The new plant, to be built with an investment of about Rs 600 crore, will be run independently of existing pharma manufacturing division, Cipla Medpro Manufacturing